Answer
Jan 20, 2025 - 01:40 PM
Glyxambi is a combination medication that includes empagliflozin and linagliptin. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, while linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. This combination is used to improve blood sugar control in adults with type 2 diabetes. For further consultation, you can contact us at our toll-free number, 1-800-891-0844, or chat with us online. We are available 24 hours a day, 7 days a week.
